Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 678,393 | 532,468 | 429,269 | 121,560 | 126,266 |
| Marketable Securities | 8,144 | 155,398 | 256,317 | 413,869 | 407,491 |
| Receivables | 41,883 | 26,252 | 26,519 | 58,540 | 28,455 |
| Inventories | 16,530 | 11,803 | 8,582 | 8,408 | 6,887 |
| TOTAL | $755,110 | $737,484 | $727,168 | $736,405 | $702,490 |
| Non-Current Assets | |||||
| PPE Net | 33,647 | 36,153 | 36,984 | 40,058 | 42,743 |
| Investments And Advances | 2,972 | 247 | 229 | 223 | 61,118 |
| Other Non-Current Assets | 35,111 | 38,131 | 43,302 | 47,691 | 51,046 |
| TOTAL | $71,730 | $74,531 | $80,515 | $87,972 | $154,907 |
| Total Assets | $826,840 | $812,015 | $807,683 | $824,377 | $857,397 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,789 | 7,553 | 5,015 | 2,865 | 6,088 |
| Accrued Expenses | 118,333 | 90,572 | 50,464 | 42,309 | 83,816 |
| TOTAL | $163,187 | $118,348 | $77,571 | $66,101 | $102,745 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,547 | 7,912 | 9,813 | 8,531 | 490 |
| Other Non-Current Liabilities | 58,339 | 83,943 | 145,141 | 106,698 | 82,187 |
| TOTAL | $222,204 | $222,736 | $314,969 | $280,647 | $219,246 |
| Total Liabilities | $385,391 | $341,084 | $392,540 | $346,748 | $321,991 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,662 | 3,640 | 3,614 | 3,564 | 3,520 |
| Common Shares | 914 | 909 | 902 | 889 | 877 |
| Retained earnings | -974,011 | -915,377 | -948,381 | -863,068 | -784,720 |
| Other shareholders' equity | 14,772 | 15,015 | 17,710 | 20,454 | 18,524 |
| TOTAL | $441,449 | $470,931 | $415,143 | $477,629 | $535,406 |
| Total Liabilities And Equity | $826,840 | $812,015 | $807,683 | $824,377 | $857,397 |